RNF157 Inhibitors
The chemical class of RNF157 inhibitors encompasses a diverse array of compounds designed to modulate the regulation and function of RNF157, an E3 ubiquitin ligase with emerging significance in cellular processes. RNF157, also known as Zinc and Ring Finger Protein 157, participates in the ubiquitin-proteasome system, playing a role in protein degradation and cellular homeostasis. Auranofin, a gold-containing compound, represents an indirect inhibitor of RNF157 by impacting the cellular redox environment. Its modulation of the thioredoxin system alters the cellular redox status, indirectly influencing RNF157 function. This highlights the intricate relationship between cellular redox balance and the regulatory mechanisms governing RNF157 activity. SB203580, classified as a p38 mitogen-activated protein kinase (MAPK) inhibitor, disrupts the MAPK signaling cascade. Its indirect modulation of RNF157 occurs through alterations in downstream targets within this vital cellular pathway. This connection underscores the interplay between RNF157 and MAPK signaling, revealing potential points of regulation within the cellular stress response.
Expanding the spectrum, PP2, a Src kinase inhibitor, and Sorafenib, a multi-kinase inhibitor, impact tyrosine kinase activity and the Raf/MEK/ERK pathway, respectively. These compounds indirectly modulate RNF157 by influencing upstream signaling events, emphasizing the interconnectedness of cellular pathways in regulating RNF157 function. Additionally, BAY 11-7082, LY294002, and I-BET151 disrupt nuclear factor-kappa B (NF-κB), phosphoinositide 3-kinase (PI3K)/AKT, and bromodomain and extra-terminal (BET) bromodomain pathways, respectively. Their indirect regulation of RNF157 occurs through altered transcriptional and signaling processes, providing a comprehensive view of the intricate network of cellular pathways influencing RNF157 function. The chemical class of RNF157 inhibitors thus unfolds as a spectrum of compounds, each wielding distinct mechanisms of action. Their convergence on intricate cellular pathways signifies a concerted effort to impact RNF157 regulation and function. Understanding these interactions provides a foundation for exploring potential strategies involving RNF157 modulation, contributing to the elucidation of the complex regulatory landscape of this E3 ubiquitin ligase.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Auranofin | 34031-32-8 | sc-202476 sc-202476A sc-202476B | 25 mg 100 mg 2 g | $153.00 $214.00 $4000.00 | 39 | |
Auranofin, a gold-containing compound, impacts the redox status of cells. It modulates the thioredoxin system, affecting cellular redox balance. This disruption indirectly influences RNF157 by altering the cellular redox environment, potentially impacting its function or regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAP kinase inhibitor, disrupts the MAPK signaling cascade. By inhibiting p38, it affects downstream targets. This interference in the MAPK pathway may indirectly regulate RNF157, as the protein is implicated in certain cellular responses influenced by MAPK signaling, providing a potential indirect inhibitory effect. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2, a Src kinase inhibitor, perturbs the tyrosine kinase activity. It disrupts signaling cascades involving Src kinases, potentially influencing cellular processes linked to RNF157. The indirect modulation of RNF157 might occur through alterations in tyrosine phosphorylation events or cross-talk with pathways where Src kinases are implicated. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib, a multi-kinase inhibitor, impacts the Raf/MEK/ERK pathway. Through its broad kinase inhibition profile, it indirectly influences RNF157 by affecting upstream signaling pathways. The modulation of key kinases in these pathways can cascade down to influence RNF157's activity or expression, providing an indirect inhibitory effect. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082, an NF-κB inhibitor, interferes with the NF-κB signaling pathway. By modulating NF-κB activity, it indirectly influences RNF157, as the protein's expression can be regulated by NF-κB. The inhibition of NF-κB may lead to altered expression levels of RNF157, impacting its cellular functions indirectly. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, disrupts the PI3K/AKT pathway. By inhibiting PI3K, it influences downstream signaling events. This disruption in the PI3K/AKT pathway may indirectly regulate RNF157, as the protein is connected to cellular processes influenced by PI3K signaling, providing a potential indirect inhibitory effect. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
I-BET151, a BET bromodomain inhibitor, affects gene transcription. By inhibiting bromodomain-containing proteins, it modulates gene expression. The indirect modulation of RNF157 may occur through altered transcriptional regulation of factors influencing RNF157 expression or function, providing an indirect inhibitory effect. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, a mTOR inhibitor, disrupts the mTOR signaling pathway. Through mTOR inhibition, it influences downstream cellular processes. This interference in the mTOR pathway may indirectly regulate RNF157, as the protein is implicated in cellular responses affected by mTOR signaling, providing a potential indirect inhibitory effect. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, disrupts the JNK signaling pathway. By inhibiting JNK, it influences downstream targets. This interference in the JNK pathway may indirectly regulate RNF157, as the protein is involved in cellular processes impacted by JNK signaling, providing a potential indirect inhibitory effect. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632, a ROCK inhibitor, perturbs the Rho/ROCK pathway. By inhibiting ROCK, it affects downstream cellular processes. This interference in the Rho/ROCK pathway may indirectly regulate RNF157, as the protein is connected to cellular responses influenced by Rho/ROCK signaling, providing a potential indirect inhibitory effect. | ||||||